02192.HK
Medlive Technology Co., Ltd.
HKSE · Healthcare · Medical - Distribution · CN
HKD 7.15
+3.47%Year over year
Reported trailing growth
- Revenue
- +2.9%
- EBITDA
- +42.8%
- EBIT
- +97.1%
- EPS
- +4.5%
- Free cash flow
- -35.6%
- Operating cash flow
- -43.5%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +26.9%
- EBITDA
- +6.6%
- EBIT
- +82.3%
- Net income
- +41.8%
- EPS
- +41.2%
- Free cash flow
- +20.4%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026